about
Optimizing drugs to reach treatment targets for children and adolescents living with HIVTreatment of young children with HIV infection: using evidence to inform policymakersMeasuring coverage in MNCH: population HIV-free survival among children under two years of age in four African countriesGetting to 90-90-90 in paediatric HIV: What is needed?Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trialWhite matter signal abnormalities in children with suspected HIV-related neurologic disease on early combination antiretroviral therapyVirologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.Scaling up paediatric HIV care with an integrated, family-centred approach: an observational case study from Uganda.Pediatric AIDS in the elimination agenda.Mortality in children and adolescents vertically infected by HIV receiving care at a referral hospital in Vitoria, Brazil.Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012.Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.Pediatric HIV/AIDS in sub-Saharan Africa: emerging issues and way forwardFive-year trends in antiretroviral usage and drug costs in HIV-infected children in ThailandEstimation of intracellular concentration of stavudine triphosphate in HIV-infected children given a reduced dose of 0.5 milligrams per kilogram twice daily.Suboptimal Viral Suppression Rates Among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-analysis.Ophthalmic manifestations of perinatally acquired HIV in a US cohort of long-term survivors.HIV-1 DNA concentrations and evolution among African HIV-1-infected children under antiretroviral treatment (ANRS 1244/1278).Authors' Reply: Early Initiation of Antiretroviral Therapy Among Young Children: A Long Way to GoTargeting 90-90-90--don't leave children and adolescents behind.Early Initiation of Antiretroviral Therapy Among Young Children: A Long Way to Go.Neglected Population, Neglected Right: Children Living with HIV and the Right to Science.
P2860
Q26774255-B86E4493-2068-4164-B650-1DA7427E0CBCQ26864053-D6C77A2D-903D-4B0F-8FC2-AC53FAC04944Q28487673-C893BC20-E957-4777-AF30-493FBAFE68DDQ30385352-CDEFFA2D-6F40-45A6-B9D2-3229438DC9E4Q33788103-175DDAFB-6FA6-49BC-BCD0-04E3D7B4C896Q34129550-64D0C587-A5B4-4BC0-8CEC-35ED8673A3FDQ34640041-847008D6-77C7-48B3-8201-68964D235B40Q34924471-AE75D46F-E365-49DF-BF23-80042D557647Q34981224-01F6B4CB-EA30-4721-8BA3-0DCF0E53615BQ35234691-2A36D32A-36CA-4CC2-ACBD-B88E558D775BQ35872045-60C5CD78-AA26-4ADE-AE73-97D5A149062DQ36300046-9FDD8D58-3B7A-4D2B-969E-413ACE2EB636Q36569786-777F4363-C995-4DDD-BE09-7BAE13B8C1E8Q37098285-6810E717-C54E-4D3B-9F9D-1368C73FFED7Q37544710-A4D13C5B-8715-439B-B6A6-890995519AF1Q38913065-2FE8A1CA-8CD8-4BA5-BC16-22F213864F96Q41652938-B826E06E-09B7-4318-B683-27C018FBFA4FQ42205378-40206127-6F0E-4C7E-8DAF-89A72A3622CAQ42318017-B2579920-2DFE-407A-B100-052B3DE66E24Q43142354-C32378D4-D1FE-4A5C-8AD3-D740846F6FFBQ43244514-445F0CA5-C96D-4707-AD71-07A24D5AB0BEQ47097059-D458863A-4DAF-4A97-8ECE-E067452D059E
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pediatric HIV — A Neglected Disease?
@ast
Pediatric HIV — A Neglected Disease?
@en
type
label
Pediatric HIV — A Neglected Disease?
@ast
Pediatric HIV — A Neglected Disease?
@en
prefLabel
Pediatric HIV — A Neglected Disease?
@ast
Pediatric HIV — A Neglected Disease?
@en
P2093
P356
P1476
Pediatric HIV — A Neglected Disease?
@en
P2093
Bernard Pecoul
Rachel Cohen
Shing Chang
P304
P356
10.1056/NEJMP1107275
P407
P577
2011-08-18T00:00:00Z